Class ITerminatedF-2399-2014
Supplement recall · September 3, 2014
PHENTALENE recall
Why: The products contain DMAA, also known as 1,3-dimethylamylamine, methylhexamine or geranium extract, which is not permitted in dietary supplements.
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
PHENTALENE (TM), PHARMACEUTICAL GRADE, With 50 mg of Ephedra Extract, 90 CAPSULES, Distributed by Beta Labs, LTD, Newark, DE 19711, UPC 670541599822
- Lots / codes
Lot # 58800512, Exp 05/16
- Quantity
- 2154 units
- Company
- Beta Labs, Memphis, TN
- Distribution
- nationwide and UK
- Initiated
- June 20, 2013 · Voluntary: Firm initiated
- Classified
- August 27, 2014
- Reported
- September 3, 2014
- Ended
- December 3, 2014
- How notified
- Press Release
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.